Login
$YARW
$13.93 +$0.00 (0.0%) After hours

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Investment in marketable securities
Amount due from sale of MST Franchise
Restricted cash
Prepaid expenses and other current assets
Total current assets
Non-current assets:
Property and equipment, net
Operating lease right of use assets (Note 9)
Non-current prepaid expenses and other assets
Other assets
Total non-current assets
Total assets
Liabilities and stockholders’ equity/(deficit)
Current liabilities:
Trade payables
Accounts Payable, Current
Accrued expenses
Employee-related obligations
Liability for employee severance benefits
Operating lease liabilities (Note 9)
Other current liabilities
Total current liabilities
Non-current operating lease liabilities (Note 9)
Other liabilities
Total Long-term Liabilities
Total liabilities
Convertible Preferred Stock: $0.0001 par value; 20,000,000 shares authorized at December 31, 2023 and December 31, 2022; Series A Preferred Stock: 0 and 3,000 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively (Note 12)
Mezzanine equity
Convertible preferred stock: $0.0001 par value; 20,000,000 shares authorized and no shares issued and outstanding at September 30, 2026, and 14,516,188 shares authorized, issued and outstanding at December 31, 2025; liquidation value of $100,000
Stockholders' equity/(deficit):
Preferred stock: $0.0001 par value; 20,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock: $0.0001 par value; 300,000,000 shares authorized and 11,473,285 shares issued and outstanding at September 30, 2026 and 29,672,628 shares authorized and 3,047,675 shares issued and outstanding at December 31, 2025
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders' equity/(deficit)
Total liabilities, convertible preferred stock and stockholders’ equity/(deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support